| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |